Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Neoplasms of the CNS

  Free Subscription


Articles published in J Neuropathol Exp Neurol

Retrieve available abstracts of 76 articles:
HTML format



Single Articles


    August 2020
  1. PETTERSON SA, Sorensen MD, Kristensen BW
    Expression Profiling of Primary and Recurrent Glioblastomas Reveals a Reduced Level of Pentraxin 3 in Recurrent Glioblastomas.
    J Neuropathol Exp Neurol. 2020 Aug 13. pii: 5892401. doi: 10.1093.
    PubMed     Abstract available


  2. QI S, Liu Y, Wang C, Fan J, et al
    Membrane Structures Between Craniopharyngioma and the Third Ventricle Floor Based on the QST Classification and Its Significance: A Pathological Study.
    J Neuropathol Exp Neurol. 2020 Aug 13. pii: 5892406. doi: 10.1093.
    PubMed     Abstract available


  3. TANG K, Gardner S, Snuderl M
    The Role of Liquid Biopsies in Pediatric Brain Tumors.
    J Neuropathol Exp Neurol. 2020 Aug 7. pii: 5882050. doi: 10.1093.
    PubMed     Abstract available


  4. MIKKELSEN VE, Dai HY, Stensjoen AL, Berntsen EM, et al
    MGMT Promoter Methylation Status Is Not Related to Histological or Radiological Features in IDH Wild-type Glioblastomas.
    J Neuropathol Exp Neurol. 2020;79:855-862.
    PubMed     Abstract available


    July 2020
  5. FURUTA T, Sugita Y, Komaki S, Ohshima K, et al
    The Multipotential of Leucine-Rich alpha-2 Glycoprotein 1 as a Clinicopathological Biomarker of Glioblastoma.
    J Neuropathol Exp Neurol. 2020 Jul 10. pii: 5869580. doi: 10.1093.
    PubMed     Abstract available


  6. GALBRAITH K, Kumar A, Abdullah KG, Walker JM, et al
    Molecular Correlates of Long Survival in IDH-Wildtype Glioblastoma Cohorts.
    J Neuropathol Exp Neurol. 2020 Jul 10. pii: 5869581. doi: 10.1093.
    PubMed     Abstract available


  7. HUIZER K, Zhu C, Chirifi I, Krist B, et al
    Periostin Is Expressed by Pericytes and Is Crucial for Angiogenesis in Glioma.
    J Neuropathol Exp Neurol. 2020 Jul 10. pii: 5869578. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  8. KAM KL, Appin CL, Mao Q, Ikegami S, et al
    Is Next-Generation Sequencing Alone Sufficient to Reliably Diagnose Gliomas?
    J Neuropathol Exp Neurol. 2020 Jun 1. pii: 5850092. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  9. GAUCHOTTE G, Peyre M, Pouget C, Cazals-Hatem D, et al
    Prognostic Value of Histopathological Features and Loss of H3K27me3 Immunolabeling in Anaplastic Meningioma: A Multicenter Retrospective Study.
    J Neuropathol Exp Neurol. 2020 May 24. pii: 5843545. doi: 10.1093.
    PubMed     Abstract available


  10. ZHU LY, Wu XY, Liu XD, Zheng DF, et al
    Aggressive Medulloblastoma-Derived Exosomal miRNAs Promote In Vitro Invasion and Migration of Tumor Cells Via Ras/MAPK Pathway.
    J Neuropathol Exp Neurol. 2020 May 17. pii: 5838430. doi: 10.1093.
    PubMed     Abstract available


  11. MUKHERJEE S, Stroberg E, Wang F, Morales L, et al
    SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
    J Neuropathol Exp Neurol. 2020;79:562-565.
    PubMed     Abstract available


  12. AHRENDSEN JT, Hsu N, Wolf Z, Bryke C, et al
    Multiple Whole Chromosomal Gains Define Angiomatous Meningiomas and Are Absent From the Tumor Vasculature.
    J Neuropathol Exp Neurol. 2020 May 1. pii: 5827861. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  13. FIORAVANZO A, Caffo M, Di Bonaventura R, Gardiman MP, et al
    A Risk Score Based on 5 Clinico-Pathological Variables Predicts Recurrence of Atypical Meningiomas.
    J Neuropathol Exp Neurol. 2020 Mar 31. pii: 5814172. doi: 10.1093.
    PubMed     Abstract available


  14. NAKATA S, Price A, Eberhart C, Morris M, et al
    Increased Tau Expression Correlates With IDH Mutation in Infiltrating Gliomas and Impairs Cell Migration.
    J Neuropathol Exp Neurol. 2020 Mar 17. pii: 5809104. doi: 10.1093.
    PubMed     Abstract available


  15. BALLESTER LY, Meis JM, Lazar AJ, Prabhu SS, et al
    Intracranial Myxoid Mesenchymal Tumor With EWSR1-ATF1 Fusion.
    J Neuropathol Exp Neurol. 2020;79:347-351.
    PubMed     Abstract available


  16. SALLE H, Pocard M, Lehmann-Che J, Bourthoumieu S, et al
    Development of a Novel Orthotopic Primary Human Chordoma Xenograft Model: A Relevant Support for Future Research on Chordoma.
    J Neuropathol Exp Neurol. 2020;79:314-324.
    PubMed     Abstract available


    February 2020
  17. BODOR C, Alpar D, Marosvari D, Galik B, et al
    Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma.
    J Neuropathol Exp Neurol. 2020;79:176-183.
    PubMed     Abstract available


    January 2020
  18. D'ARCY CE, Nobre LF, Arnaldo A, Ramaswamy V, et al
    Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples.
    J Neuropathol Exp Neurol. 2020 Jan 30. pii: 5735424. doi: 10.1093.
    PubMed     Abstract available


  19. HEWER E, Phour J, Gutt-Will M, Schucht P, et al
    TERT Promoter Mutation Analysis to Distinguish Glioma From Gliosis.
    J Neuropathol Exp Neurol. 2020 Jan 29. pii: 5740035. doi: 10.1093.
    PubMed     Abstract available


  20. HO CY, Bornhorst M, Almira-Suarez MI, Donev K, et al
    Clinicopathologic Features of Diencephalic Neuronal and Glioneuronal Tumors.
    J Neuropathol Exp Neurol. 2020;79:67-73.
    PubMed     Abstract available


  21. KLEINSCHMIDT-DEMASTERS BK
    Pituitary Adenomas in Transgender Individuals?
    J Neuropathol Exp Neurol. 2020;79:62-66.
    PubMed     Abstract available


    December 2019
  22. MARTIN AM, Bell WR, Yuan M, Harris L, et al
    PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of BRAF V600E Mutational Status.
    J Neuropathol Exp Neurol. 2019 Dec 9. pii: 5670883. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  23. PI CASTRO D, Jose-Lopez R, Fernandez Flores F, Rabanal Prados RM, et al
    Expression of FOXP3 in Canine Gliomas: Immunohistochemical Study of Tumor-Infiltrating Regulatory Lymphocytes.
    J Neuropathol Exp Neurol. 2019 Nov 11. pii: 5679984. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  24. RICHARDSON TE, Tang K, Vasudevaraja V, Serrano J, et al
    GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.
    J Neuropathol Exp Neurol. 2019 Sep 16. pii: 5593615. doi: 10.1093.
    PubMed     Abstract available


  25. CHKHEIDZE R, Cimino PJ, Hatanpaa KJ, White CL, et al
    Distinct Expression Patterns of Carbonic Anhydrase IX in Clear Cell, Microcystic, and Angiomatous Meningiomas.
    J Neuropathol Exp Neurol. 2019 Sep 12. pii: 5582700. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  26. LEAL LF, Cavagna RO, Campanella NC, Mancano B, et al
    Lack of KBTBD4 Mutations in Molecularly Classified Brazilian Medulloblastomas.
    J Neuropathol Exp Neurol. 2019 Aug 12. pii: 5548001. doi: 10.1093.
    PubMed     Abstract available


  27. KESSLER R, Fleischer M, Springsguth C, Bigl M, et al
    Prognostic Value of PFKFB3 to PFKFB4 mRNA Ratio in Patients With Primary Glioblastoma (IDH-Wildtype).
    J Neuropathol Exp Neurol. 2019 Aug 1. pii: 5542689. doi: 10.1093.
    PubMed     Abstract available


    July 2019
  28. ZHANG H, Qin D, Jiang Z, Zhang J, et al
    SNHG9/miR-199a-5p/Wnt2 Axis Regulates Cell Growth and Aerobic Glycolysis in Glioblastoma.
    J Neuropathol Exp Neurol. 2019 Jul 23. pii: 5555858. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  29. ROY S, Agnihotri S, El Hallani S, Ernst WL, et al
    Clinical Utility of GlioSeq Next-Generation Sequencing Test in Pediatric and Young Adult Patients With Brain Tumors.
    J Neuropathol Exp Neurol. 2019 Jun 10. pii: 5531629. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  30. DAHLROT RH, Larsen P, Boldt HB, Kreutzfeldt MS, et al
    Posttreatment Effect of MGMT Methylation Level on Glioblastoma Survival.
    J Neuropathol Exp Neurol. 2019 May 6. pii: 5486005. doi: 10.1093.
    PubMed     Abstract available


  31. KOMAKI S, Sugita Y, Furuta T, Yamada K, et al
    Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With Glioblastomas.
    J Neuropathol Exp Neurol. 2019;78:389-397.
    PubMed     Abstract available


  32. LEE S, Kambhampati M, Yadavilli S, Gordish-Dressman H, et al
    Differential Expression of Wilms' Tumor Protein in Diffuse Intrinsic Pontine Glioma.
    J Neuropathol Exp Neurol. 2019;78:380-388.
    PubMed     Abstract available


    April 2019
  33. RICHARDSON TE, Patel S, Serrano J, Sathe AA, et al
    Genome-Wide Analysis of Glioblastoma Patients with Unexpectedly Long Survival.
    J Neuropathol Exp Neurol. 2019 Apr 29. pii: 5481410. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  34. LI M, Zeng L, Liu S, Dangelmajer S, et al
    Transforming Growth Factor-beta Promotes Homing and Therapeutic Efficacy of Human Mesenchymal Stem Cells to Glioblastoma.
    J Neuropathol Exp Neurol. 2019 Mar 12. pii: 5376675. doi: 10.1093.
    PubMed     Abstract available


  35. TREVISAN P, Graziadio C, Rodrigues DBK, Rosa RFM, et al
    Clinical and Molecular Characterization of Adult Glioblastomas in Southern Brazil.
    J Neuropathol Exp Neurol. 2019 Mar 6. pii: 5370415. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  36. TEGLASI V, Csury DT, Dezso K, Bugyik E, et al
    Origin and Distribution of Connective Tissue and Pericytes Impacting Vascularization in Brain Metastases With Different Growth Patterns.
    J Neuropathol Exp Neurol. 2019 Feb 28. pii: 5366830. doi: 10.1093.
    PubMed     Abstract available


  37. TORRE M, Meredith DM, Dubuc A, Solomon DA, et al
    Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features.
    J Neuropathol Exp Neurol. 2019 Feb 9. pii: 5366829. doi: 10.1093.
    PubMed     Abstract available


  38. XU C, Mao L, Xiong J, Wen J, et al
    TAZ Expression on Endothelial Cells Is Closely Related to Blood Vascular Density and VEGFR2 Expression in Astrocytomas.
    J Neuropathol Exp Neurol. 2019;78:172-180.
    PubMed     Abstract available


  39. AHN JS, Harrison W, Hughes E, McLendon RE, et al
    Intraventricular Pilocytic Astrocytoma With KIAA1549/BRAF Fusion Arising in a 44-Year Old.
    J Neuropathol Exp Neurol. 2019;78:187-190.
    PubMed     Abstract available


    January 2019
  40. PARILLA M, Kadri S, Patil SA, Fitzpatrick C, et al
    Integrating a Large Next-Generation Sequencing Panel into the Clinical Diagnosis of Gliomas Provides a Comprehensive Platform for Classification from FFPE Tissue or Smear Preparations.
    J Neuropathol Exp Neurol. 2019 Jan 28. pii: 5303810. doi: 10.1093.
    PubMed     Abstract available


  41. BERTERO L, Dalla Dea G, Osella-Abate S, Botta C, et al
    Prognostic Characterization of Higher-Grade Meningiomas: A Histopathological Score to Predict Progression and Outcome.
    J Neuropathol Exp Neurol. 2019 Jan 25. pii: 5301682. doi: 10.1093.
    PubMed     Abstract available


  42. DAOUD EV, Wachsmann M, Richardson TE, Mella D, et al
    Spinal Pleomorphic Xanthoastrocytoma With a QKI-RAF1 Fusion.
    J Neuropathol Exp Neurol. 2019;78:10-14.
    PubMed     Abstract available


  43. LIPP ES, Healy P, Austin A, Clark A, et al
    MGMT: Immunohistochemical Detection in High-Grade Astrocytomas.
    J Neuropathol Exp Neurol. 2019;78:57-64.
    PubMed     Abstract available


    September 2018
  44. LIU Y, Qi ST, Wang CH, Pan J, et al
    Pathological Relationship Between Adamantinomatous Craniopharyngioma and Adjacent Structures Based on QST Classification.
    J Neuropathol Exp Neurol. 2018 Sep 14. pii: 5098259. doi: 10.1093.
    PubMed     Abstract available


    August 2018
  45. KOEHLER JW, Miller AD, Miller CR, Porter B, et al
    A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma.
    J Neuropathol Exp Neurol. 2018 Aug 27. pii: 5103388. doi: 10.1093.
    PubMed     Abstract available


  46. CANTERO D, Rodriguez de Lope A, Moreno de la Presa R, Sepulveda JM, et al
    Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing.
    J Neuropathol Exp Neurol. 2018;77:710-716.
    PubMed     Abstract available


    June 2018
  47. THOMPSON EM, Brown M, Dobrikova E, Ramaswamy V, et al
    Poliovirus Receptor (CD155) Expression in Pediatric Brain Tumors Mediates Oncolysis of Medulloblastoma and Pleomorphic Xanthoastrocytoma.
    J Neuropathol Exp Neurol. 2018 Jun 6. pii: 5033817. doi: 10.1093.
    PubMed     Abstract available


  48. CHENG YC, Tsao MJ, Chiu CY, Kan PC, et al
    Magnolol Inhibits Human Glioblastoma Cell Migration by Regulating N-Cadherin.
    J Neuropathol Exp Neurol. 2018;77:426-436.
    PubMed     Abstract available


    May 2018
  49. GIANTINI LARSEN A, Grannan BL, Lee CK, Koch MJ, et al
    Malignant Melanoma Metastatic to Oligodendroglioma: Case Report and Literature Review of Tumor-to-Tumor Metastasis to Gliomas.
    J Neuropathol Exp Neurol. 2018 May 8. pii: 4993991. doi: 10.1093.
    PubMed     Abstract available


    April 2018
  50. FERGUSON SD, Zhou S, Huse JT, de Groot JF, et al
    Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas.
    J Neuropathol Exp Neurol. 2018 Apr 27. pii: 4989444. doi: 10.1093.
    PubMed     Abstract available


    February 2018
  51. DAOUD EV, Rajaram V, Cai C, Oberle RJ, et al
    Adult Brainstem Gliomas With H3K27M Mutation: Radiology, Pathology, and Prognosis.
    J Neuropathol Exp Neurol. 2018 Feb 10. pii: 4851722. doi: 10.1093.
    PubMed     Abstract available


    December 2017
  52. YAO ZG, Li WH, Hua F, Cheng HX, et al
    LBH589 Inhibits Glioblastoma Growth and Angiogenesis Through Suppression of HIF-1alpha Expression.
    J Neuropathol Exp Neurol. 2017;76:1000-1007.
    PubMed     Abstract available


  53. ESCHBACHER JM, Georges JF, Belykh E, Yazdanabadi MI, et al
    Immediate Label-Free Ex Vivo Evaluation of Human Brain Tumor Biopsies With Confocal Reflectance Microscopy.
    J Neuropathol Exp Neurol. 2017;76:1008-1022.
    PubMed     Abstract available


    November 2017
  54. SHI QY, Feng X, Bao W, Ma J, et al
    MYC/BCL2 Co-Expression Is a Stronger Prognostic Factor Compared With the Cell-of-Origin Classification in Primary CNS DLBCL.
    J Neuropathol Exp Neurol. 2017;76:942-948.
    PubMed     Abstract available


    October 2017
  55. FOO ASC, Tan DTM, Tan CL, Sahm F, et al
    Report of a Novel Case of Anaplastic Olfactory Groove Meningioma and Its Methylation Subtype.
    J Neuropathol Exp Neurol. 2017 Oct 16. doi: 10.1093.
    PubMed     Abstract available


  56. AL-HAJRI A, Al-Mughairi S, Somani A, An S, et al
    Pathology-MRI Correlations in Diffuse Low-Grade Epilepsy Associated Tumors.
    J Neuropathol Exp Neurol. 2017 Oct 12. doi: 10.1093.
    PubMed     Abstract available


  57. HANNEN R, Hauswald M, Bartsch JW
    A Rationale for Targeting Extracellular Regulated Kinases ERK1 and ERK2 in Glioblastoma.
    J Neuropathol Exp Neurol. 2017;76:838-847.
    PubMed     Abstract available


  58. FORSSTROM LM, Sumi K, Makinen MJ, Oh JE, et al
    Germline MSH6 Mutation in a Patient With Two Independent Primary Glioblastomas.
    J Neuropathol Exp Neurol. 2017;76:848-853.
    PubMed     Abstract available


  59. RICHARDSON TE, Shen ZJ, Kanchwala M, Xing C, et al
    Aggressive Behavior in Silent Subtype III Pituitary Adenomas May Depend on Suppression of Local Immune Response: A Whole Transcriptome Analysis.
    J Neuropathol Exp Neurol. 2017;76:874-882.
    PubMed     Abstract available


    September 2017
  60. DONSON AM, Apps J, Griesinger AM, Amani V, et al
    Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma.
    J Neuropathol Exp Neurol. 2017;76:779-788.
    PubMed     Abstract available


    August 2017
  61. SCHWEIZER Y, Meszaros Z, Jones DTW, Koelsche C, et al
    Molecular Transition of an Adult Low-Grade Brain Tumor to an Atypical Teratoid/Rhabdoid Tumor Over a Time-Course of 14 Years.
    J Neuropathol Exp Neurol. 2017;76:655-664.
    PubMed     Abstract available


  62. PRATT D, Pittaluga S, Palisoc M, Fetsch P, et al
    Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma.
    J Neuropathol Exp Neurol. 2017;76:697-708.
    PubMed     Abstract available


    July 2017
  63. RYALL S, Arnoldo A, Krishnatry R, Mistry M, et al
    Multiplex Detection of Pediatric Low-Grade Glioma Signature Fusion Transcripts and Duplications Using the NanoString nCounter System.
    J Neuropathol Exp Neurol. 2017;76:562-570.
    PubMed     Abstract available


  64. AMANI V, Donson AM, Lummus SC, Prince EW, et al
    Characterization of 2 Novel Ependymoma Cell Lines With Chromosome 1q Gain Derived From Posterior Fossa Tumors of Childhood.
    J Neuropathol Exp Neurol. 2017;76:595-604.
    PubMed     Abstract available


    May 2017
  65. BARRESI V, Caffo M
    Rhabdoid Meningioma: Grading and Prognostic Significance of This Uncommon Variant.
    J Neuropathol Exp Neurol. 2017;76:414-416.
    PubMed    


    April 2017
  66. BARRESI V, Lionti S, Valori L, Gallina G, et al
    Dual-Genotype Diffuse Low-Grade Glioma: Is It Really Time to Abandon Oligoastrocytoma As a Distinct Entity?
    J Neuropathol Exp Neurol. 2017 Apr 17. doi: 10.1093.
    PubMed     Abstract available


  67. AMES H, Halushka MK, Rodriguez FJ
    miRNA Regulation in Gliomas: Usual Suspects in Glial Tumorigenesis and Evolving Clinical Applications.
    J Neuropathol Exp Neurol. 2017;76:246-254.
    PubMed     Abstract available


    March 2017
  68. BOULAGNON-ROMBI C, Fleury C, Fichel C, Lefour S, et al
    Immunohistochemical Approach to the Differential Diagnosis of Meningiomas and Their Mimics.
    J Neuropathol Exp Neurol. 2017 Mar 14. doi: 10.1093.
    PubMed     Abstract available


  69. BALLESTER LY, Fuller GN, Powell SZ, Sulman EP, et al
    Retrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary Brain Tumors.
    J Neuropathol Exp Neurol. 2017;76:179-188.
    PubMed     Abstract available


  70. BRUNER JM, Louis DN, McLendon R, Rosenblum MK, et al
    The Utility of Expert Diagnosis in Surgical Neuropathology: Analysis of Consultations Reviewed at 5 National Comprehensive Cancer Network Institutions.
    J Neuropathol Exp Neurol. 2017;76:189-194.
    PubMed     Abstract available


    January 2017
  71. ROBINSON C, Kleinschmidt-DeMasters BK
    IDH1-Mutation in Diffuse Gliomas in Persons Age 55 Years and Over.
    J Neuropathol Exp Neurol. 2017 Jan 21. pii: nlw112. doi: 10.1093.
    PubMed     Abstract available


  72. GOSCHZIK T, Gessi M, Dreschmann V, Gebhardt U, et al
    Genomic Alterations of Adamantinomatous and Papillary Craniopharyngioma.
    J Neuropathol Exp Neurol. 2017 Jan 9. pii: nlw116. doi: 10.1093.
    PubMed     Abstract available


  73. ASSLABER M, Schauer S, Gogg-Kamerer M, Bernhart E, et al
    Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by WIF1 Expression.
    J Neuropathol Exp Neurol. 2017;76:16-26.
    PubMed     Abstract available


  74. JAPP AS, Klein-Hitpass L, Denkhaus D, Pietsch T, et al
    OTX2 Defines a Subgroup of Atypical Teratoid Rhabdoid Tumors With Close Relationship to Choroid Plexus Tumors.
    J Neuropathol Exp Neurol. 2017;76:32-38.
    PubMed     Abstract available


    November 2016
  75. YUAN JX, Bafakih FF, Mandell JW, Horton BJ, et al
    Quantitative Analysis of the Cellular Microenvironment of Glioblastoma to Develop Predictive Statistical Models of Overall Survival.
    J Neuropathol Exp Neurol. 2016.
    PubMed     Abstract available


  76. LING C, Pouget C, Rech F, Pflaum R, et al
    Endothelial Cell Hypertrophy and Microvascular Proliferation in Meningiomas Are Correlated with Higher Histological Grade and Shorter Progression-Free Survival.
    J Neuropathol Exp Neurol. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: